Merck has announced two supply interruptions:
• Adult formulation of Vaqta, a hepatitis A vaccine – anticipated return: Q3 2017
• Adult formulation of RecombivaxHB, a hepatitis B vaccine – anticipated return: Q3 2018
Please note that these interruptions should not impact the supply of the pediatric formulation of either Vaqta or RecombivaxHB.
If you have any questions, please contact your Merck representative or the CPP office at email@example.com.
The May 19, 2017, Morbidity and Mortality Weekly Report includes the Advisory Committee on Immunization Practices’ updated dosing schedule recommendations for TRUMENBA® (serogroup B meningococcal vaccine).
To read the updated recommendations, please click here.
CPP will be attending and exhibiting at the AMGA annual conference in Grapevine, TX March 22-25. Stop by the booth and see what new resources we have to help you manage your vaccines more cost effectively!
Medically unlikely edits (MUEs) are the daily limit placed by the Centers for Medicare & Medicaid Services (CMS) on billed CPT codes and are often used by private payers to reduce the likelihood of coding errors. With the assistance of the Section on Administration and Practice Management (SOAPM) and the Committee on Coding and Nomenclature (COCN), the Academy worked with CMS to update the MUEs associated with the vaccine administration codes 90460 and 90461 based on clinical rationale.
The updates are as follows:
- Effective April 1, 2017, the MUE for 90460 will go from 6 to 9
- Effective July 1, 2016, the MUE for 90461 will go from 5 to 8 (Since this update was published January 1, 2017 but was effective July 1, 2016, any denials since this date should be appealed.)
If you receive denials for MUEs, email the AAP coding hotline at firstname.lastname@example.org. (Full Article)
Merck has announced a price increase to Zostavax effective January 6, 2017. The new pricing will become effective for CPP members on April 6, 2017. For updated pricing sheets, please contact the CPP office at email@example.com or 614-722-2145.
Sanofi Pasteur is now accepting orders for Quadracel™ (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine). Doses are available in a 10-dose package, vial presentation (NDC# 49281-562-10; see full product information).
Orders can be placed now by going to http://www.VaccineShoppe.com and are expected to ship in February 2017.
The Sanofi Pasteur Fluzone® Partner pricing and terms for the upcoming 2017-2018 flu season have been announced and sent to our membership. If you are a CPP member and did not receive the details, please contact us.
The pre-book period is now open and you can make your flu reservation at any time by going to http://www.VaccineShoppe.com. Reservations must be confirmed by March 31, 2017.
If you have any questions or need additional information, please don’t hesitate to contact the CPP office at 614-722-2145 or your Sanofi Pasteur representative.